ArticleJournal for immunotherapy of cancer2024

TNFR2 blockade promotes antitumoral immune response in PDAC by targeting activated Treg and reducing T cell exhaustion.

Anais Debesset et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.